GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging Neurochem Res 1991
Kiraly 2015
GHK-Cus mechanism depends on gradual tissue accumulation over the cycle, not on high single-day concentrations
N h tr sn xut nng lng khi bn vn ng, c bit l trong cc bi tp cng cao, nhanh v mnh nh nng t, chy nc rt, Khi c s dng di dng thc phm b sung, Creatine gip tng sc mnh, sc bn, ci thin hiu sut tp luyn
Improves Exercise Performance L-carnitine is known to improve exercise performance by increasing the body's ability to burn fat for fuel